Related references
Note: Only part of the references are listed.Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes
Kjersti Morkrid et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity
Bee K. Tan et al.
DIABETES (2011)
Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
Zhuofeng Lin et al.
PLOS ONE (2011)
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
David A. Sarruf et al.
DIABETES (2010)
Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction
A. N. Pathmaperuma et al.
PLACENTA (2010)
Risk Factors for Type 2 Diabetes Among Women with Gestational Diabetes: A Systematic Review
Kesha Baptiste-Roberts et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus
Ke Li et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Success of Programming Fetal Growth Phenotypes Among Obese Women
Hamisu M. Salihu et al.
OBSTETRICS AND GYNECOLOGY (2009)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Cecilia Gaelman et al.
CELL METABOLISM (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Plasma FGF-21 levels in type 2 diabetic patients with ketosis
Ling Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
Association between obesity during pregnancy and increased use of health care
Susan Y. Chu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The fasting polypeptide FGF21 can enter brain from blood
Hung Hsuchou et al.
PEPTIDES (2007)
Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons
Pablo J. Enriori et al.
CELL METABOLISM (2007)
Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines
J Chen et al.
DIABETOLOGIA (2006)
Gestational diabetes: dilemma caused by multiple international diagnostic criteria
MM Agarwal et al.
DIABETIC MEDICINE (2005)
Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies
M Lappas et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes
CA Crowther et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Early pregnancy insulin resistance and subsequent gestational diabetes mellitus
KV Smirnakis et al.
DIABETES CARE (2005)
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
T Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
